Gerhard Prante, a director at Cibus, Inc. (NASDAQ:CBUS), a small-cap biotechnology company with a market capitalization of $85.45 million, recently sold 1,150 shares of the company's Class A common ...
Some results have been hidden because they may be inaccessible to you